EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Liver-Targeted Tolerogenic Lipid Nanoparticles for Treating Autoimmune Diseases

Hemant Singh, Sarthak Samuel Singh, Vikram Sawant, Chhavi Sharma, Hina Khan, Rukshana Mangattu Veettil, Tarun Kumar Upadhyay, Fawzi Banat, Shabir Hassan

International Journal of Nanomedicine · 2026-11 · Volume 21 · 1-22

DOI: 10.2147/ijn.s619772 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2026-11. Verfasst von Hemant Singh und 8 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Singh, H., Singh, S. S., Sawant, V., Sharma, C., Khan, H., Veettil, R. M., Upadhyay, T. K., Banat, F., & Hassan, S. (2026). Liver-Targeted Tolerogenic Lipid Nanoparticles for Treating Autoimmune Diseases. International Journal of Nanomedicine, Volume 21, 1-22. https://doi.org/10.2147/ijn.s619772

Vancouver

Singh H, Singh SS, Sawant V, Sharma C, Khan H, Veettil RM, et al. Liver-Targeted Tolerogenic Lipid Nanoparticles for Treating Autoimmune Diseases. International Journal of Nanomedicine. 2026;Volume 21:1-22. doi:10.2147/ijn.s619772

BibTeX
@article{Singh2026,
  author = {Singh, Hemant and Singh, Sarthak Samuel and Sawant, Vikram and Sharma, Chhavi and Khan, Hina and Veettil, Rukshana Mangattu and Upadhyay, Tarun Kumar and Banat, Fawzi and Hassan, Shabir},
  title = {Liver-Targeted Tolerogenic Lipid Nanoparticles for Treating Autoimmune Diseases},
  journal = {International Journal of Nanomedicine},
  year = {2026},
  volume = {Volume 21},
  pages = {1--22},
  doi = {10.2147/ijn.s619772}
}
Kostenlos starten →